Tag: release

TORONTO, May 16, 2022 /PRNewswire/ -- The INX Digital Company, Inc. (NEO: INXD) (the "Company"), the owner of digital asset trading platforms, a broker-dealer, and an inter-dealer broker, announced financial ...

NEW DELHI, May 16, 2022 /PRNewswire/ -- Five Seats of Power is an invaluable guide to becoming the best one can be. It uses insights from the Yoga Shastra and the ...

New York, May 13, 2022 (GLOBE NEWSWIRE) -- According to the statistics by the Pan American Health Organization (PAHO), of the World Health Organization (WHO), neurological conditions regionwide in the ...

Sarclisa® (isatuximab) combination provides unprecedented median progression free survival in patients with relapsed multiple myeloma receiving a proteasome inhibitor therapy Latest results of the Phase 3 IKEMA trial demonstrate the ...

PRESS RELEASE: 13 May 2022, 17:40 CEST Results of the Annual Shareholders’ Meeting held on 13 May 2022 Mechelen, Belgium, 13 May 2022 – Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an ...

FORT WORTH, Texas, May 12, 2022 (GLOBE NEWSWIRE) -- Event: Fiscal Year Earnings Release Webcast   Hosts: Michael Combs, President and Chief Executive Officer  Brandon O’Brien, Chief Financial Officer   Date: Thursday May 26, 2022   Time:  11:30 am EST.   Contact: Investor Relations ...

LOS ANGELES, May 11, 2022 (GLOBE NEWSWIRE) -- Music royalties-based NFT ecosystem, Band Royalty, has made history by creating the world's first multi-track music NFT. Music industry mogul Rob Schwartz ...

LOS ANGELES and SINGAPORE, April 29, 2022 (GLOBE NEWSWIRE) -- Our Happy Company, the company behind social NFT platform OurSong, has partnered with Yuki Tsuji, master of the Japanese flower ...

OMAHA, Neb.--(BUSINESS WIRE)--(BRK.A; BRK.B) – Berkshire’s operating results for the first quarters of 2022 and 2021 are summarized in the following paragraphs. However, we urge investors and reporters to read ...

TORONTO, April 29, 2022 (GLOBE NEWSWIRE) -- Theralase® Technologies Inc. (“Theralase” or the “Company”) (TSXV: TLT) (OTCQB: TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of ...